OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
September 03, 2014
Conventional tablets may no longer be the go-to solution.
September 02, 2014
Advances in engineered particles and the subsequent reduction in the API mass required to achieve a therapeutic dose can lead to a reduction in side effects.
The role of add-on devices and how they affect drug delivery with a pressurized metered dose inhaler.
September 01, 2014
A surge in generic drug applications is testing FDA?s ability to reduce the backlog of ANDAs.
August 29, 2014
The National Institute of Allergy and Infectious Diseases will begin the first in a series of trials for an Ebola vaccine during the week of Sept. 1.
August 15, 2014
Concerns about quality in overseas production may bring generic drug production back to the United States, concludes CPhI study.
August 07, 2014
The European system for assessing drugs will be used as a model internationally.
August 04, 2014
EMA has released the second module of a new guideline on influenza vaccines for a six-month public consultation. The guidance covers the non-clinical and clinical requirements for the development of new influenza vaccines and aims to facilitate the prompt assessment of new vaccines. It follows the publication of a module on the quality requirements.
August 02, 2014
Customers are looking to reduce risk, increase performance, and optimize productivity.
FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.